Company intelligence / Profile preview

BMF Precision

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

The company has developed advanced organ-on-a-chip platforms that replicate physiologically relevant human tissues at scale. These platforms have demonstrated promising results in recapitulating tissue function for drug discovery and cosmetic testing applications. Early models include tumor-on-a-chip, skin-on-a-chip, and kidney-on-a-chip systems.

Therapeutic areas: DermatologyOther
Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Actively seeking collaboration partners in pharma/biotech/cosmetics sectors for further development of the BioChip platform

Beyond the preview

Go deeper on BMF Precision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMF Precision.

Explore the full profile